SELENOP and type 2 diabetes mellitus: In addition, studies have suggested that the role of SELENOP in GD and T2D might reduce the adiponectin levels by affecting adipose tissue [20,72], and the adiponectin levels are known to be negatively correlated with LDL-C [117].